Updated survival outcome of regorafenib, ipilimumab, and nivolumab in refractory microsatellite stable non-liver metastatic colorectal cancer: A phase I nonrandomized clinical trial
Annie Xiao, Xiaochen Li, Chongkai Wang, Jian Ye, Marwan Fakih
Topics & Concepts
RegorafenibNivolumabIpilimumabMedicineColorectal cancerRefractory (planetary science)Internal medicineOncologyMicrosatellite instabilityPhases of clinical researchClinical trialCancerImmunotherapyMicrosatelliteBiologyAlleleGeneBiochemistryAstrobiologyColorectal Cancer Treatments and StudiesCancer Immunotherapy and BiomarkersMelanoma and MAPK Pathways